PTEN and cancer: In a panel of human cancer cell lines of different histological origin, including isogenic colorectal cancer cell lines only differing for PTEN status, PTEN-loss effectively predicted synergistic growth inhibitory interactions between RAF/MEK and PI3K/AKT/mTOR inhibitors.